| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.5 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.47 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |